CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a ...

Scott Drutman Incoming Chief Medical Officer of Enara Bio Boehringer Ingelheim exercises option to license additional Dark ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

GSK licenses Noetik’s AI foundation models in anchor partnership to transform cancer therapeutic research and development ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

Increased use of organoids in cancer research: The Würzburg lighthouse project "Preclinical Models" is working towards this ...